Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Accumulated Depreciation (2019 - 2020)

Pliant Therapeutics has reported Accumulated Depreciation over the past 2 years, most recently at $3.5 million for Q4 2020.

  • Quarterly Accumulated Depreciation rose 59.41% to $3.5 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Dec 2020, up 59.41% year-over-year, with the annual reading at $3.5 million for FY2020, 59.41% up from the prior year.
  • Accumulated Depreciation was $3.5 million for Q4 2020 at Pliant Therapeutics, up from $3.2 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $3.5 million in Q4 2020 and troughed at $2.2 million in Q4 2019.